{"schema_version":"secwatch.filing_event.v1","accession":"0001323885-25-000041","form_type":"8-K","ticker":"ATRC","cik":"0001323885","company_name":"AtriCure, Inc.","filed_at":"2025-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.918323+00:00","generated_at":"2026-05-23T03:32:13.832926+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AtriCure Q1 revenue $123.6M (+13.6% YoY); net loss improves to $6.7M from $13.2M","bullets":["Revenue $123.6M (+13.6% YoY; +14.1% constant currency); U.S. $101.1M (+12.1%), International $22.5M (+20.8%).","Net loss $6.7M ($0.14 per share) improved from $13.2M ($0.28 per share) a year ago.","Adjusted EBITDA $8.8M, up from $2.8M in Q1 2024; gross margin 74.9% (+27 bps).","Growth driven by EnCompass clamp, cryoSPHERE MAX probes, AtriClip Flex-Mini device launches."],"urls":{"canonical":"https://secwatch.observer/filing/0001323885-25-000041","json":"https://secwatch.observer/filing/0001323885-25-000041.json","markdown":"https://secwatch.observer/filing/0001323885-25-000041.md","text":"https://secwatch.observer/filing/0001323885-25-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000041/0001323885-25-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000041/atrc-20250429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T03:32:13.832926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}